Dissertation > Excellent graduate degree dissertation topics show

Distribution of Hyaluronic Acid in Lung Xenograft of Nude Mice and the Trace-study of Ha Specific Binding Protein (p-CLP)

Author: LiuZhiQiang
Tutor: QiangYongGang
School: Guangzhou Medical College
Course: Medical Imaging and Nuclear Medicine
Keywords: Lung tumors HA distribution Purification and characterization of p-CLP Marking and tracing
CLC: R734.2
Type: Master's thesis
Year: 2010
Downloads: 9
Quote: 0
Read: Download Dissertation

Abstract


Objective: In the process of the study of human cancer, liver disease, ophthalmic disease, bone disease and other diseases, found in the blood of hyaluronic acid (HA) content is higher than normal. HA is mainly distributed in the mesenchymal cells, the combination of these HA expressed in form of a complex with a covalent bond with the cartilage chain protein (CLP). Certain concentrations of guanidine hydrochloride the CLP and HA dissociation, nobody reported pig cartilage chain protein (p-CLP) in vivo distribution and metabolic processes. To this end, we have discussed the following: ① The isolation of p-CLP; ② p-CLP, with HA vitro binding characteristics; (3) lung transplantation in nude mice with HA tumor learning distribution; ④ p-CLP in nude mice lung transplant tissue distribution. Hope that the above study, p-CLP biology and experimental nuclear medicine imaging studies underlying data to provide experimental evidence for the early diagnosis of lung tumor imaging and other diseases. Methods: The animal model of lung adenocarcinoma tumor learning and HA distribution in A549 cells inoculated BALB / C-nunu tumor-bearing nude mice were reared 3,4,5,6 weeks immunohistochemistry SP method determination of HA distribution within the tumor in the lung transplantation nude mice of different ages. 2. P-CLP separation, purification and identification of affinity chromatography and separation from porcine costal cartilage purified p-CLP, through epichlorohydrin activated Sepharose 4B Preparation of HA-AH-Sepharose 4B affinity chromatography, p-CLP crude products homogenate, enzymatic hydrolysis, dialysis, concentrated, and passed through a column purification made of p-CLP; then the SDS-PAGE gel electrophoresis analysis of the molecular weight of the p-CLP; p-CLP amino acid analysis to determine the content of amino acids, p-CLP; competition in the external beam radiotherapy combined analysis of the determination of the p-CLP HA affinity characteristics. Iodine mark of 3.p-CLP and tracer analysis the the Na125I chloramine-T oxidation tag p-CLP, and explore the optimal reaction conditions, preparation of high specific activity of the radioactive probe; tracer distribution experiment through to lung transplantation nude tail vein injection of 125I-p-CLP, 5min, 20min, 30min, 45min, 1h, 1.5h, 3h, 5h, 7h period of time the mice were sacrificed, blood and vital organs measuring radioactivity in the p-CLP nude mice in vivo metabolism and distribution parameters. Results: HA immunostaining positive rate of 93%, immunohistochemistry 3-6 weeks positive tissue optical density values ??were 150.78 ± 10.25,160.13 ± 8.54,176.83 ± 13.46,185.95 ± 13.61, the control group was 37.43 ± 5.17. The t-test showed that each group was statistically significant (P lt; 0.05). The immunohistochemistry Law vaccination 3-6 weeks in nude mice with the time extension of the vaccination, HA expression gradually increased, the HA is mainly distributed in the tumor cells surrounding stromal tumor HA expression rich, normal tissue expression was weak. 2 affinity chromatography and extraction p-CLP, the UV scanning into a single peak, the to extract protein yield was 2.21%, the SDS-PAGE electrophoresis p-CLP two bands, respectively (44.36 ± 2.90) KD p-CLP HA affinity constant (71.58 ± 4.13) KD; p-CLP amino acid analysis glutamate levels in the highest (2.26mg/20mg) tyrosine content 0.91mg/20mg; competitive binding analysis of external beam radiation experiments show Ka (6.30 ± 1.73) x 109M-1 3.p-CLP, mark display when 125I activity for 0.925MBq and there are significant differences the 1.85MBq 3.7MBq 7.4MBq groups labeling rate (all P lt; 05) the 7.4MBq 11.1MBq, 14.8MBq group labeling rate differences (all P gt; 0.05); chloramine-T concentration 0.312mg/ml stamp rate 0.625mg/ml with other groups differences (all P lt; 0, 05), other markers showed no difference (all P gt; 0.05); 30s-8min mark time mark rate in each group there was no difference (both P gt; 0.05); 125I activity concentration of chloramine-T, marking time on the radiochemical purity of little effect, each group no significant differences (all P gt; 0.05); chloramine-T concentration 0.625mg/ml and mark time 1min 125I-p-CLP biological binding highest activity; distribution of the p-CLP tracer experiments show that, when the concentration of the p-CLP in vivo 20min peak, with the time, p-CLP distribution within the tumor percentage gradually increased. Conclusion: 1.HA in lung tumor tissue, the increasing trend, wherein the periphery of the tumor cells, interstitial excessive expression, with the extension of the time of tumor growth, HA expression increased with the growth of the tumor cells. P-CLP labeling conditions: the 125I 7.4MBq 1.25mg/ml chloramine-T 30 μl p-CLP 0.5mg reaction volume of 100 μl of reaction 1min. Tracer experiments, p-CLP in early nude mice was systemic distribution, metabolism by the liver, in part by renal excretion, HA-specific binding in the nude mouse lung tumor model p-CLP and lung tumor cells in the interstitial .

Related Dissertations

  1. Effect of Chlorin e6/SDT and Paclitaxel on the Proliferation of Human Lung Adenocarcinoma Cell SPCA-1,R734.2
  2. The Expression and Clinical Significance of Cyclooxygenase-2 in Non-small Cell Lung Cancer,R734.2
  3. Study on the Immunity of Patients with Lung Cancer and the Effects of Chemotherapy on the Immunity,R734.2
  4. Effects of Survivin siRNA on Proliferation of Human Lung Cancer Cell Lines and Chemosensitivity of Paclitaxel,R734.2
  5. Preoperative and Postoperative Study of Lung Volume Reduction Surgery and Lung Cancer Resection Using Quantitative CT,R816.4
  6. Value of PET/CT in Predicting Outcome and Lymph Node Staging of Patients with Resected Lung Cancer,R734.2
  7. Chemoprevention of Passive Smoking-Induced Lung Tumors Development in Mice with Dietary Supplementation of Vitamin E,R734.2
  8. Analysis of Clinical Characteristics of Lung Cancer Confirmed by Bronchoscopy and Autofluorescence Bronchoscopy for Diagnosis of Tumor Extension in Lung Cancer,R734.2
  9. Analyses of the Therapeutic Effect about the BACE United PEI in Lung Cancer,R734.2
  10. The Clinical Value of CHO and FDG PET in Diagnosis of Lung Cancer and Comparison with Perfusion CT in a Rabbit Model,R734.2
  11. Experimental Study on Radio-genetic Therapy Using a Hypoxia/radiation Dual-sensitive Promoter in A549 Lung Adenocarcinoma Cells and Its Xenografted Tumors in Nude Mice,R734.2
  12. Study on Gene Expression Patterns of Low-differentiated Human Lung Adenocarcinoma at Stage Ⅰ and Clinical Significance of Expression Status of Cyclin D1, MMP-2 and pRb,R734.2
  13. Studies on the Bioeffects and Carcinogenicity of Sterigmatocystin in Vitro and in Vivo,R730.2
  14. Pulmonary Nodules: Metabolic and Morphological Characteristics by 18F-FDG PET-CT and CT,R816.4
  15. The Study of 18F-FDG PET-CT in the Staging of Non-Small Cell Lung Cancer,R734.2
  16. The Study of Inhibitory Effect and Mechanism with Diphosphonate on the Lung Cancer Cell Line A549 in Vitro,R734.2
  17. Diagnostic Study of TTF-1 and HBME-1 in Pleural Effusion of Patients with Lung Cancer,R734.2
  18. The Effects of CYP1A1 Gene Polymorphism and p16 Gene Methylation on the Risk of Lung Cancer,R734.2
  19. The Effects of Various Radiotherapies in Lung Cancer with Brain Metastasis,R739.4
  20. The Effects of NACT to Expression of MMP-2/TIMP-2 of NSCLC,R734.2

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile